APRE

Aprea Therapeutics Inc

May 15 • 04:00PM ET

0.9301

-0.0109 -1.16 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SLS BLRX APVO CUE IMNN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.54	Insider Own	12.76%	Shs Outstand	11.98M	Perf Week	-5.08%
Market Cap	11.52M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	3.96%	Shs Float	10.92M	Perf Month	2.47%
Enterprise Value	-34.22M	PEG	-	EPS next Q	-0.18	Inst Own	38.68%	Short Float	0.94%	Perf Quarter	52.63%
Income	-11.95M	P/S	96.00	EPS this Y	64.64%	Inst Trans	4.25%	Short Ratio	0.23	Perf Half Y	-26.18%
Sales	0.12M	P/B	0.26	EPS next Y	4.40%	ROA	-34.99%	Short Interest	0.10M	Perf YTD	9.04%
Book/sh	3.51	P/C	0.25	EPS next 5Y	27.68%	ROE	-40.07%	52W High	2.22 -58.10%	Perf Year	-48.33%
Cash/sh	3.75	P/FCF	-	EPS past 3/5Y	88.77% 47.99%	ROIC	-27.92%	52W Low	0.55 69.73%	Perf 3Y	-74.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	82.39%	Volatility	9.74% 10.14%	Perf 5Y	-98.87%
Dividend TTM	-	EV/Sales	-285.17	EPS Y/Y TTM	34.76%	Oper. Margin	-10202.01%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.92	Sales Y/Y TTM	-90.40%	Profit Margin	-9696.04%	RSI (14)	55.79	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.92	EPS Q/Q	65.87%	SMA20	4.82%	Beta	1.51	Target Price	4.30
Payout	-	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	13.05%	Rel Volume	0.26	Prev Close	0.94
Employees	8	LT Debt/Eq	0.00	Earnings	May 13 BMO	SMA200	-16.20%	Avg Volume	444.94K	Price	0.93
IPO	Oct 03, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	-3.53% -	Trades		Volume	116,302	Change	-1.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)